Mr. Jarrett Malnarick reports
VIRIDIUM TO RESUME TRADING FEBRUARY 13 2019
Upon inquiry by Viridium Pacific Group Ltd., the TSX Venture Exchange has confirmed that the trading halt, imposed on Viridium's common shares, will be lifted at market open on Feb. 13, 2019 (not Feb. 11, 2019, as originally conveyed). The trading halt was a requirement by the TSX Venture Exchange in connection with Viridium's proposed acquisition of EFX Laboratories Inc., which was completed today.
About Viridium Pacific Group Ltd.
Viridium Pacific Group is a consumer wellness, medical and biotech innovation company based in British Columbia and the parent company of operating subsidiaries involved in horticultural production (Experion Biotechnologies), medical product production (EFX Labs) property development (Fish Trap Ventures Ltd.) and human resource management (Stave Lake Services Ltd.). Experion Biotechnologies is a Health Canada-licensed producer of cannabis, which operates in an 8,300-square-foot indoor facility outside of Mission, B.C.
© 2019 Canjex Publishing Ltd. All rights reserved.